Here are the Form 4 insider transactions from Vicor Corp (VICR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow VICR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VICR filings page.
Vicor Corp director reports option exercise and share sale
A Vicor Corp director reported exercising a non-qualified stock option for 2,000 shares of common stock at an exercise price of $39.25 per share on 11/17/2025, acquiring 2,000 shares. On the same date, the director reported selling 2,000 shares of common stock at a price of $87.69 per share, leaving 0 shares of common stock directly owned after the transactions.
Following these transactions, the director reported beneficial ownership of 6,000 non-qualified stock options. The filing states that the sale was effected under a Rule 10b5-1 trading plan adopted on September 12, 2024, and notes that the options expire one year from each vesting date.
Vicor Corp (VICR) reported insider activity by a corporate vice president/director on 11/12/2025. The insider exercised non-qualified stock options for 6,404 shares at strike prices of $31.05, $32.89, $53.07, $60.61, and $75.43, and sold 6,404 shares at $94.5799.
Following the transactions, the insider directly owns 33,622 shares of common stock. The activity reflects same-day option exercises (code M) paired with open market sales (code S) at the stated prices.
Vicor Corporation (VICR) director Andrew D'Amico reported option exercises and same-day open-market sales on November 12, 2025.
He exercised non-qualified stock options for 577 shares at $69.04 and sold 577 shares at $98.44; exercised another 577 shares at $69.04 and sold 577 shares at $100; and exercised 754 shares at $53.07 and sold 754 shares at $99. The filing notes these sales were effected under a Rule 10b5-1 trading plan adopted on September 12, 2024.
After these transactions, the option grant with a $69.04 exercise price shows 0 derivative securities remaining, while the grant with a $53.07 exercise price shows 3,015 derivative securities remaining.